Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese Participants

Clinical trial NCT05070312 · COMPLETED

Trial details

NCT number: NCT05070312
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2021-08-23
Primary completion: 2022-02-07
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.